Search Records

Health Canada and the Canadian Advertising Preclearance Agencies (APAs) share the common goal of maintaining integrity in health product advertising. The purpose of this guidance document is to inform staff and stakeholders of the different roles these organizations play in achieving this goal.

This strategy document outlines the steps to be taken in order to optimize the use of RWE to improve the safety and effectiveness of medical devices across the product life cycle. As well, the plan describes the activities and the outputs required to achieve the objectives.

On April 28, 2016, Health Canada, the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the New Zealand Ministry for Primary Industries (NZMPI) simultaneously approved a new use for pain relief in sheep for the veterinary drug Metacam.

Part of Health Canada’s work as a regulator is to engage and inform Canadians on issues about their health. Learn how we use consultations and other tools to help protect and improve the health of Canadians.

The Public Health Agency of Canada’s (PHAC) COVID-19 immunization recommendations for individuals previously vaccinated with COVID-19 vaccines not authorized by Health Canada is intended to support local, territorial, and provincial, decision-making by public health departments and health care...

At Health Canada our role is to help Canadians maintain and improve their health. While the provinces and territories are responsible for delivering healthcare to the majority of Canadians, the federal government also has a number of key roles and responsibilities in areas that affect health and...

The Office of Audit and Evaluation (OAE) Departmental Evaluation Plan for PHAC describes the Program Evaluation Division's scheduled work for the five-year period from 2021-22 to 2025-26. The Plan was developed to meet PHAC's commitments under the Policy on Results (2016), which requires that...

The Public Health Agency of Canada (PHAC) launched the Vaccine Community Innovation Challenge on March 8, 2021, to seek creative ideas for community-based information initiatives. This is the Backgrounder for the Funding Recipients.

In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged, including from Israel and the United States. Follow-up on these cases is ongoing. No clear...

The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines...